IFNB1 and breast cancer: In the current studies, we have observed that TPT, as well as many other chemotherapeutics and ionizing radiation, induces elevated MHC I expression in breast cancer cells through induction of IFN-β, suggesting that elevated tumor antigen presentation through IFN-β autocrine/paracrine signaling could represent a common mechanism underlying tumor immune sensitization by cancer therapeutics.